AIDS Treatment News - 2004
- AIDS Treatment News - 2004
- Issue #398
- Antiretroviral Pipeline: New-Drug Reports from Retroviruses Conference
- FDA Advisory Hearing on New-Fill (Sculptra), March 25, 2004 in Gaithersburg, Maryland
- Lipodystrophy: Conference on Imaging Technologies in Clinical Management, Montreal, April 2-3, 2004
- Micronutrient Supplementation Shows Promise in Placebo-Controlled Trial
- Nevirapine Precautions Published
- Prison HIV and Hepatitis C Sites
- "Poppers," Some Other Drugs, May Increase HIV Infection Risk
- New Testing for Very Early HIV Diagnosis
- No January 2004 Issue of AIDS Treatment News
- Improving AIDS Conferences with Online Information
- Issue #399
- Clinton Foundation Negotiates $140/Year HIV Treatment, But U.S. Won't Buy
- Atherosclerosis Risk Increased with HIV; Treatment Effects Unclear
- Atazanavir (Reyataz): New Recommendations If Combined with Tenofovir (Viread) -- and Warning on Viagra, Cialis, and Levitra
- Abacavir Hypersensitivity Reaction Predicted by Genetic Test
- Update on Sculptra (New-Fill) Hearing
- Lessons from Two
- Retroviruses Conference: Summaries for Physicians
- Medicines for the World: A Way Forward
- Issue #400
- TMC125: Important One-Year Trial Now Recruiting in U.S.
- Gonorrhea: New Treatment Recommendations for Gay Men, MSM
- May 20
- How to Network Action Alerts, So That Others Can Help
- Online Glossaries of HIV/AIDS Terms
- Checking Your Drug Interactions
- Inexpensive Air Filter for Allergy Relief
- Issue #401
- New Medicare-Approved Prescription Drug Discount Card
- Institute of Medicine Urges Restructuring of U.S. Low-Income HIV Treatment and Care
- ADAP Crisis National Call-In Alert, Starting June 14
- Grants for Innovative Treatment, Vaccine, or Microbicide Research, Application Deadline July 31
- Bangkok AIDS Conference May Be Largest Ever, July 11 to 16
- Ronald Reagan Remembered
- Issue #402
- Bangkok Conference, July 11-16; Getting News Online
- U.S. Researcher Starts Treatment Fund in Uganda: Interview with David Bangsberg, M.D., M.P.H.
- President Bush on AIDS: More Questions Than Answers
- Abstinence, Abstinence-Only, Faith-Based, and the Psychology of Stigma
- Medical Marijuana: Important Vote Coming, You Can Help
- ADVAX, New DNA Vaccine in Human Trial; HIV-Negative Volunteers Needed in New York City or Rochester, NY Areas
- Drug Resistance Workshop (June 2004) Summaries Available
- Issue #403
- Chronically Depressed Women with HIV Almost Twice As Likely As Others to Die from AIDS-Related Causes; Those with Mental-Health Services Had Half the Death Rate of Those Without
- Cambodia Stops Important Tenofovir Prevention Trial
- Hepatitis Coinfection: Two Major Studies Published
- FDA Approves Two Combination Pills, Epzicom and Truvada; Comment on Commercial Race to Once-a-Day Nucleosides
- Smarter Clinical Trials for Faster Drug Development
- Retroviruses Conference Date Set
- HIV Treatment and Immunology Research: Current Ideas
- Issue #404
- ADAP Activists Needed in All U.S. States and Territories
- ACT UP: Enormous Worldwide Attention to New York Demos
- Medical Information from Bangkok Conference: Clinical Care Options Site
- AIDSVote: Election Information and Activism
- Elections: Widespread Misinformation on Who Can Vote
- Nutrition: Call for Information -- What Has Been Most Helpful to You?
- Medical Marijuana Rescheduling Rally, Washington DC October 5
- Empty Antibiotic Pipeline Critically Endangers Public: IDSA Report
- Clinical Trials: Philadelphia Hospitals Combine to Form "Supersite" and Reduce Delays
- AIDS Treatment and Related Conference Calendar (Starting September 2004)
- Issue #405
- Depression: Louganis and Allen to Speak at Forums in New York, and San Francisco Oct. 27
- New Fixed-Dose Once-a-Day Starting Regimens: Interview with Cal Cohen, M.D.
- Warning Against Using Erythromycin (Even Orally) While Using Protease Inhibitors or Certain Other Drugs
- Kaletra Monotherapy Controversy: AmfAR Publishes Overview
- Access to NIH-Funded Research Information -- Public Comment Period to November 16, 2004
- Issue #406
- Saving AIDS Conferences Online: Interview with Sister Mary Elizabeth, Founder of AEGiS
- Warning on Two Specific 3-Drug Regimens: Viread + Didanosine + Either Sustiva or Viramune
- New Treatment Guidelines Published October 29
- Retroviruses Conference: Community Deadlines, Nov. 23
- World AIDS Day, December 1: Women and Girls
- Prison Health Care: Activist Campaign Targets Hepatitis, HIV Care for Prisoners, and Continuity of Care After Release
- After the Election
- Issue #407
- Weekend Treatment Interruptions for Certain Well-Controlled Patients: Interview with Cal Cohen, M.D.
- Sculptra (Formerly New Fill) for Facial Wasting -- Where to Find Information on the Patient-Assistance Program
- Nevirapine Misinformation: Will It Kill?
- Missing Conferences Followup: Four Meetings' History Found
- Buyers' Club List, December 2004
- AIDS Treatment News Index, 2004
- Issue #408
- Behind "AIDS Breakthrough" Headlines, December 2004: Important Research, Not So New
- Warning: Do Not Combine Reyataz and Prilosec
- Treatment Interruption: Most Patients Could Not Maintain Immune Control
- India Changes Patent Law to Meet WTO Treaty, Making New Medicines Less Available to Most Citizens, Other Countries
- Africa: Children’s Access to Prophylaxis May Improve After Medical Study, New WHO Recommendations
- Retroviruses Conference Reminder: You Must Complete Housing Process to Attend
- Behind "AIDS Breakthrough" Headlines, December 2004: Important Research, Not So New
- Warning: Do Not Combine Reyataz and Prilosec
- India Changes Patent Law to Meet WTO Treaty, Making New Medicines Less Available to Most Citizens, Other Countries
- Africa: Children's Access to Prophylaxis May Improve After Medical Study, New WHO Recommendations
- Treatment Interruption: Most Patients Could Not Maintain Immune Control
- Retroviruses Conference Reminder: You Must Complete Housing Process to Attend
- Weekend Treatment Interruptions for Certain Well-Controlled Patients: Interview with Cal Cohen, M.D.
- Sculptra (Formerly New Fill) for Facial Wasting -- Where to Find Information on Patient-Assistance Program
- Missing Conferences Followup: Four Meetings' History Found
- Buyers' Club List, December 2004
- Nevirapine Misinformation: Will It Kill?
- Saving AIDS Conferences Online: Interview with Sister Mary Elizabeth, Founder of AEGiS
- Warning on Two Specific 3-Drug Regimens: Viread + Videx + Either Sustiva or Viramune
- New Treatment Guidelines Published October 29
- Retroviruses Conference: Community Deadlines, Nov. 23
- World AIDS Day, December 1: Women and Girls
- Prison Health Care: Activist Campaign Targets Hepatitis, HIV Care for Prisoners, and Continuity of Care After Release
- After the Election
- New Fixed-Dose Once-a-Day Starting Regimens: Interview with Cal Cohen, M.D.
- Depression: Louganis and Allen Speak at Forum in New York, and in San Francisco Oct. 27
- Warning Against Using Erythromycin (Even Orally) While Using Protease Inhibitors or Certain Other Drugs
- Kaletra Monotherapy Controversy: AmfAR Publishes Overview
- Access to NIH-Funded Research Information -- Public Comment Period to November 16, 2004
- ADAP Activists Needed in All U.S. States and Territories
- ACT UP: Enormous Worldwide Attention to New York Demos
- Medical Information from Bangkok Conference: Clinical Care Options Site
- AIDSVote: Election Information and Activism
- Elections: Widespread Misinformation on Who Can Vote
- Nutrition: Call for Information -- What Has Been Most Helpful to You?
- Medical Marijuana Rescheduling Rally, Washington DC October 5
- Empty Antibiotic Pipeline Critically Endangers Public: IDSA Report
- Clinical Trials: Philadelphia Hospitals Combine to Form "Supersite" and Reduce Delays
- AIDS Treatment and Related Conference Calendar (Starting September 2004)
- Chronically Depressed Women with HIV Almost Twice As Likely As Others to Die from AIDS-Related Causes; Those with Mental-Health Services Had Half the Death Rate of Those Without
- Cambodia Stops Important Tenofovir Prevention Trial
- Hepatitis Coinfection: Two Major Studies Published
- FDA Approves Two Combination Pills, Epzicom and Truvada; Comment on Commercial Race to Once-a-Day Nucleosides
- Smarter Clinical Trials for Faster Drug Development
- Retroviruses Conference Date Set
- HIV Treatment and Immunology Research: Current Ideas
- Bangkok Conference, July 11-16; Getting News Online
- U.S. Researcher Starts Treatment Fund in Uganda: Interview with David Bangsberg, M.D., M.P.H.
- President Bush on AIDS: More Questions Than Answers
- Abstinence, Abstinence-Only, Faith-Based, and the Psychology of Stigma
- Medical Marijuana: Important Vote Coming, You Can Help
- ADVAX, New DNA Vaccine in Human Trial; HIV-Negative Volunteers Needed in New York City or Rochester, NY Areas
- Drug Resistance Workshop (June 2004) Summaries Available
- New Medicare-Approved Prescription Drug Discount Card
- Institute of Medicine Urges Restructuring of U.S. Low-Income HIV Treatment and Care
- ADAP Crisis National Call-In Alert, Starting June 14
- Inexpensive Air Filter for Allergy Relief
- Grants for Innovative Treatment, Vaccine, or Microbicide Research, Application Deadline July 31
- Bangkok AIDS Conference May Be Largest Ever, July 11 to 16
- Ronald Reagan Remembered
- TMC125: Important One-Year Trial Now Recruiting in U.S.
- Gonorrhea: New Treatment Recommendations for Gay Men, MSM
- May 20 "Time's Up!" AIDS Protest in Washington D.C.
- How to Network Action Alerts, So That Others Can Help
- Online Glossaries of HIV/AIDS Terms
- Checking Your Drug Interactions
- Clinton Foundation Negotiates $140/Year HIV Treatment, But U.S. Won't Buy
- Atherosclerosis Risk Increased with HIV; Treatment Effects Unclear
- Abacavir Hypersensitivity Reaction Predicted by Genetic Test
- Update on Sculptra (New-Fill) Hearing
- Lessons from Two "Triple Nuke" Failures (New Training Module)
- Retroviruses Conference: Summaries for Physicians
- Medicines for the World: A Way Forward
- Atazanavir (Reyataz) New Recommendations If Combined with Tenofovir (Viread) -- and Warning on Viagra, Cialis, and Levitra
- Action Alerts: Please Improve Them for Networking
- FDA Advisory Hearing on New-Fill (Sculptra), March 25, 2004 in Gaithersburg, Maryland
- Antiretroviral Pipeline: New-Drug Reports from Retroviruses Conference
- Nevirapine Precautions Published
- Micronutrient Supplementation Shows Promise in Placebo-Controlled Trial
- Lipodystrophy: Conference on Imaging Technologies in Clinical Management, Montreal, April 2-3, 2004
- "Poppers," Some Other Drugs, May Increase HIV Infection Risk
- New Testing for Very Early HIV Diagnosis
- Improving AIDS Conferences with Online Information
- Institute of Medicine Calls for Universal Health Insurance by 2010
- Greg Smith in prison
- Greg Smith funeral demonstration at sentencing judge's home
- Remembering Greg Smith
source: AIDS Treatment News




